The University of Chicago is home to one of the most respected and recognized cancer programs in the nation. Our multidisciplinary pediatric cancer care team has the expertise and resources to provide comprehensive evaluation, treatment and management of lymphoma in infants, young children and adolescents. And the same physicians who take care of our pediatric lymphoma patients are the ones who are developing new ways to treat the disease with chemotherapy, targeted therapies and stem cell transplants, with the goal of maintaining excellent cure rates while minimizing the late effects of treatment.
In fact, University of Chicago scientists have been leaders in changing treatment protocols for adolescents and young adults with leukemia, lymphoma and other hematologic malignancies. This research helped lay the foundation for our Adolescent and Young Adult (AYA) Oncology Program. Serving patients ages 15 through 30 with leukemia, lymphoma, and other cancers, the program recognizes the unique medical, social and emotional challenges that this population faces and provides specialized, coordinated care. Our team of pediatric and adult hematologists/oncologists develops individualized treatment plans that help patients experience a life that is not limited by their diagnosis, and include the support of social workers, psychologists, physical therapists, and fertility specialists. » Learn more about our program for adolescents and young adults with lymphoma.